Skip to main content

La Jolla Pharmaceutical Co

LJPCDelisted Aug 22, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000920465

La Jolla Pharmaceutical Co was delisted on Aug 22, 2022; its insiders filed their last Form 4 on Aug 24, 2022; 41 institutions reported holding it in 13F filings for Q2 2022, worth $53.9M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding La Jolla Pharmaceutical Co changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of LJPC: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6254−8
Shares18.4M17.8M−581.5K (−3.2%)
Value$78.6M$70.9M−$7.65M (−9.7%)

New holders (6)

Institutions that held La Jolla Pharmaceutical Co at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to LJPC in Q3 2021
InstitutionSharesValue% of portfolio
HealthInvest Partners AB270,000$1.08M1.61%
Renaissance Technologies LLC45,836$183.0K0.00%
Globeflex Capital L P27,089$108.0K0.02%
HighVista Strategies LLC25,493$102.0K0.07%
Virtu Financial LLC21,258$85.0K0.01%
Connor, Clark & Lunn Investment Management Ltd.10,094$40.0K0.00%

Sold out (14)

Institutions that held La Jolla Pharmaceutical Co at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of LJPC in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Tibra Equities Europe Ltd72,600$311.0K
Employees Retirement System of Texas56,540$242.0K
Susquehanna International Group, LLP50,722$217.0K
Summit Global Investments48,500$208.0K
Jane Street Group, LLC35,924$154.0K
Marshall Wace, LLP15,572$67.0K
Squarepoint Ops LLC13,227$57.0K
LMR Partners LLP11,515$49.0K
PDT Partners, LLC10,585$45.0K
ExodusPoint Capital Management, LP10,073$43.0K
Panagora Asset Management Inc1,018$4.00K
New York State Common Retirement Fund156$1.00K
Group One Trading, L.P.283$1.00K
Citigroup Inc1$0